Here's the live share price of Akums Drugs & Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Akums Drugs & Pharmaceuticals | 1.63 | 11.80 | 28.71 | 63.72 | 28.26 | -4.48 | -2.71 |
| Sun Pharmaceutical Industries | 0.21 | 4.62 | 16.32 | 19.76 | 16.13 | 21.11 | 23.00 |
| Divi's Laboratories | -0.11 | 8.44 | 14.63 | 21.76 | 9.90 | 25.66 | 8.67 |
| Torrent Pharmaceuticals | 0.50 | 11.38 | 21.28 | 28.03 | 41.47 | 37.32 | 27.00 |
| Cipla | -2.50 | -2.75 | 6.73 | 6.00 | -5.40 | 9.95 | 8.01 |
| Zydus Lifesciences | -3.46 | 0.13 | 17.58 | 26.27 | 15.73 | 21.98 | 12.61 |
| Lupin | -3.96 | 1.88 | 2.60 | 12.34 | 25.02 | 36.82 | 15.24 |
| Mankind Pharma | 0.66 | 1.26 | 11.77 | 21.83 | -1.51 | 10.40 | 12.46 |
| Dr. Reddy's Laboratories | -4.69 | -10.36 | -12.49 | -5.56 | -6.50 | 2.65 | 1.47 |
| Aurobindo Pharma | -1.39 | -0.58 | 6.32 | 34.72 | 36.67 | 24.81 | 9.64 |
| Laurus Labs | 0.69 | 5.91 | 38.94 | 54.19 | 90.72 | 65.09 | 19.35 |
| Biocon | -1.27 | 2.78 | 21.60 | 18.75 | 9.64 | 20.40 | 1.79 |
| Alkem Laboratories | -1.46 | 3.86 | 1.87 | -2.19 | 12.94 | 14.14 | 10.62 |
| Glenmark Pharmaceuticals | -3.72 | 1.00 | -5.76 | 11.76 | 2.99 | 40.80 | 27.65 |
| Abbott India | 4.91 | 14.37 | 15.06 | 5.10 | -15.82 | 8.03 | 10.43 |
| Ipca Laboratories | -6.01 | 9.50 | 16.71 | 21.49 | 21.58 | 30.98 | 10.05 |
| Anthem Biosciences | 2.79 | 0.72 | 5.33 | 28.03 | 3.28 | 2.22 | 1.32 |
| Ajanta Pharma | 1.47 | 9.73 | 25.90 | 29.61 | 28.79 | 34.92 | 19.35 |
| GlaxoSmithKline Pharmaceuticals | -0.43 | 4.09 | 0.18 | 7.98 | -20.27 | 21.48 | 8.22 |
| Gland Pharma | -5.79 | 3.82 | 32.72 | 41.88 | 17.01 | 24.41 | -9.89 |
Source: Dion Global
Over the last one year, Akums Drugs & Pharmaceuticals has gained 28.26% compared to peers like Sun Pharmaceutical Industries (16.13%), Divi's Laboratories (9.90%), Torrent Pharmaceuticals (41.47%). From a 5 year perspective, Akums Drugs & Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (23.00%) and Divi's Laboratories (8.67%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 681.97 | 682.28 |
| 10 | 678.73 | 674.06 |
| 20 | 652.38 | 654.42 |
| 50 | 593.25 | 608.93 |
| 100 | 548.83 | 565.86 |
| 200 | 496.5 | 539.27 |
Source: Dion Global
In the latest quarter, Akums Drugs & Pharmaceuticals remained same as its previous close in promoter holding, while DII stake decreased to 13.44%, FII holding rose to 1.91%, and public shareholding moved up to 6.67% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 25,33,367 | 1.72 | 157.87 | |
| 22,30,054 | 0.97 | 138.97 | |
| 21,80,445 | 2.05 | 135.87 | |
| 17,73,851 | 0.39 | 110.54 | |
| 16,48,135 | 0.73 | 102.7 | |
| 14,89,317 | 1.03 | 92.81 | |
| 10,23,743 | 0.12 | 63.79 | |
| 6,00,000 | 1.82 | 37.39 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jul 11, 2026, 11:58 PM IST IST | Akums Drugs&Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Jul 10, 2026, 11:51 PM IST IST | Akums Drugs&Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Jul 08, 2026, 09:34 PM IST IST | Akums Drugs&Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jul 04, 2026, 11:34 PM IST IST | Akums Drugs&Pharma. - Update On Penalty Imposed By The Deputy Commissioner Of State Tax, Gujarat, On Maxcure Nutravedics Limi |
| Jun 19, 2026, 04:26 PM IST IST | Akums Drugs&Pharma. - Notice And Integrated Annual Report For The Financial Year 2025-26 To Those Members Who Have Not Regist |
Source: Dion Global
Akums Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 19/04/2004 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L24239DL2004PLC125888 and registration number is 25888. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1348.74 Cr. and Equity Capital is Rs. 30.62 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Akums Drugs & Pharmaceuticals is ₹694.00 as on Jul 23, 2026.
The Akums Drugs & Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Akums Drugs & Pharmaceuticals is ₹10,923.14 Cr as on Jul 23, 2026.
Today’s highest and lowest price of Akums Drugs & Pharmaceuticals are ₹701.00 and ₹687.10.
The 52-week high/low is the highest and lowest price at which Akums Drugs & Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Akums Drugs & Pharmaceuticals is ₹713.80 and 52-week low of Akums Drugs & Pharmaceuticals is ₹410.10 as on Jul 23, 2026.
The Akums Drugs & Pharmaceuticals has shown returns of -0.34% over the past day, 11.8% for the past month, 28.71% over 3 months, 28.26% over 1 year, -4.48% across 3 years, and -2.71% over 5 years.
P/E ratio of and PB ratio of Akums Drugs & Pharmaceuticals are 42.80 and 3.30 on Jul 23, 2026. While the company gives a dividend yield of 0.43 per annum.
Source: Dion Global